ProMIS Neurosciences

Compare

273 Followers

PMN Stock Chart & Stats

$0.46

-$0.04(-3.74%)

At close: Jan 08 4:00 PM EST

$0.46

-$0.04(-3.74%)

Day’s Range― - ―

52-Week Range$0.38 - $1.59

Previous CloseN/A

Volume32.49K

Average Volume (3M)819.50K

Market Cap

$23.22M

Enterprise Value$12.32M

Total Cash (Recent Filing)$4.54M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta0.67

Next Earnings

Nov 12, 2025

EPS Estimate

-0.24

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.29

Shares Outstanding53,811,110

10 Day Avg. Volume1,049,009

30 Day Avg. Volume819,497

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.53

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-1.46

Forecast

1Y Price Target

$3.00

Price Target Upside552.17% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Clinical Study ProgressProMIS announced that it received approval from the independent Data and Safety Monitoring Board (DSMB) to advance to the final dose escalation cohort in its ongoing P1b study of PMN310 for Alzheimer's disease.

Financial StabilityProMIS further strengthened its balance sheet by raising $21.6M in gross proceeds through July 2025 financing activities and launching an ~$18M ATM offering, which combined should provide funding into 2026.

Safety And EfficacyThe recommendation followed the review of fully enrolled cohort 2, which demonstrated no cases of amyloid-related imaging abnormalities, a significant safety risk in existing amyloid treatments.

Bears Say

ProMIS Neurosciences News

ProMIS Neurosciences Advances Alzheimer’s Study with PMN310

ProMIS Neurosciences Inc. (($PMN)) announced an update on their ongoing clinical study. ProMIS Neurosciences Inc. is conducting a...

3d ago

PMN

ProMIS Neurosciences Appoints New Board Member

ProMIS Neurosciences ( ($PMN) ) just unveiled an announcement. On October 22, 2025, ProMIS Neurosciences announced the appointment...

6d ago

PMN

ProMIS Neurosciences Amends Employment Agreement with CSO

The latest update is out from ProMIS Neurosciences ( ($PMN) ). On September 26, 2025, ProMIS Neurosciences Inc....

1M ago

PMN

ProMIS Neurosciences files to sell 28.23M common shares for holders

16:34 EDT ProMIS Neurosciences (PMN) files to sell 28.23M common shares for holders Published first on TheFly –...

2M ago

PMN

Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on ProMIS Neurosciences. The associated price target...

2M ago

PMN

ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase

ProMIS Neurosciences ( ($PMN) ) has issued an update. On September 3, 2025, ProMIS Neurosciences announced that the...

2M ago

PMN

ProMIS receives DSMB approval to advance final dose escalation cohort

ProMIS Neurosciences (PMN) announced that the independent Data and Safety Monitoring Board, DSMB, for its ongoing PRECISE-AD Phase...

2M ago

PMN

ProMIS Neurosciences Announces At The Market Offering

ProMIS Neurosciences ( ($PMN) ) has issued an announcement. On August 13, 2025, ProMIS Neurosciences Inc. announced an...

2M ago

PMN

ProMIS Neurosciences: Advancements in Alzheimer’s Treatment and Strong Financial Positioning Drive Buy Rating

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on ProMIS Neurosciences, with a price target of...

3M ago

PMN

ProMIS Neurosciences Reports Increased R&D Expenses and Net Loss

ProMIS Neurosciences Inc. ( ($PMN) ) has released its Q2 earnings. Here is a breakdown of the information...

3M ago

PMN

ProMIS Neurosciences files $50M mixed securities shelf

16:38 EDT ProMIS Neurosciences (PMN) files $50M mixed securities shelf Published first on TheFly – the ultimate source...

3M ago

PMN

ProMIS Neurosciences reports Q2 EPS (29c) vs (13c) last year

“The team’s exceptional focus and execution in the first half of 2025 culminated in what has been an...

3M ago

PMN

ProMIS Neurosciences to present overview from PRECISE-AD trial

ProMIS Neurosciences (PMN) announced it has been invited to present an overview of its ongoing PRECISE-AD trial in...

3M ago

PMN

ProMIS Neurosciences Announces $3M PIPE Offering

ProMIS Neurosciences ( ($PMN) ) has shared an update. On July 28, 2025, ProMIS Neurosciences announced a private...

3M ago

PMN

PMN FAQ

What was ProMIS Neurosciences’s price range in the past 12 months?

ProMIS Neurosciences lowest stock price was $0.38 and its highest was $1.59 in the past 12 months.

What is ProMIS Neurosciences’s market cap?

ProMIS Neurosciences’s market cap is $23.22M.

When is ProMIS Neurosciences’s upcoming earnings report date?

ProMIS Neurosciences’s upcoming earnings report date is Nov 12, 2025 which is in 13 days.

How were ProMIS Neurosciences’s earnings last quarter?

ProMIS Neurosciences released its earnings results on Aug 13, 2025. The company reported -$0.29 earnings per share for the quarter, missing the consensus estimate of -$0.174 by -$0.116.

Is ProMIS Neurosciences overvalued?

According to Wall Street analysts ProMIS Neurosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ProMIS Neurosciences pay dividends?

ProMIS Neurosciences does not currently pay dividends.

What is ProMIS Neurosciences’s EPS estimate?

ProMIS Neurosciences’s EPS estimate is -0.24.

How many shares outstanding does ProMIS Neurosciences have?

ProMIS Neurosciences has 53,811,110 shares outstanding.

What happened to ProMIS Neurosciences’s price movement after its last earnings report?

ProMIS Neurosciences reported an EPS of -$0.29 in its last earnings report, missing expectations of -$0.174. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of ProMIS Neurosciences?

Currently, no hedge funds are holding shares in PMN

Company Description

ProMIS Neurosciences

ProMIS Neurosciences (PMN) is a biotechnology company focused on the discovery and development of precision therapeutics for neurodegenerative diseases, particularly Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company utilizes its proprietary technology platform to selectively target misfolded proteins implicated in these diseases, aiming to develop disease-modifying treatments. ProMIS Neurosciences operates primarily in the biotechnology and pharmaceutical sectors, leveraging advanced scientific research to address unmet medical needs in neurodegenerative conditions.

ProMIS Neurosciences (PMN) Earnings & Revenues

Historic Earnings Reports

PMN Stock 12 Month Forecast

Average Price Target

$3.00

▲(552.17% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","5":"$5","8":"$8","11":"$11","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,2,5,8,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Dec<br/>2024","9":"May<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.54,0.7292307692307692,0.9184615384615384,1.1076923076923078,1.2969230769230768,1.4861538461538462,1.6753846153846155,1.8646153846153846,2.0538461538461537,2.243076923076923,2.4323076923076923,2.6215384615384614,2.810769230769231,{"y":3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.54,0.7292307692307692,0.9184615384615384,1.1076923076923078,1.2969230769230768,1.4861538461538462,1.6753846153846155,1.8646153846153846,2.0538461538461537,2.243076923076923,2.4323076923076923,2.6215384615384614,2.810769230769231,{"y":3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.54,0.7292307692307692,0.9184615384615384,1.1076923076923078,1.2969230769230768,1.4861538461538462,1.6753846153846155,1.8646153846153846,2.0538461538461537,2.243076923076923,2.4323076923076923,2.6215384615384614,2.810769230769231,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.36,"date":1585699200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.7,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.92,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.91,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.95,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.75,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.65,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.77,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.54,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >